Equity raise in Oda Group Holding AB (SE) – SEK 1,265 million Consumer & Retail Equity raise in Oda Group Holding AB (SE) – SEK 1,265 million
Private placement in Lytix Biopharma AS (NO) — NOK 100 million Healthcare Private placement in Lytix Biopharma AS (NO) — NOK 100 million
Sale of secondary shares in Stronghold AB (SE) – SEK 390 million FIG Sale of secondary shares in Stronghold AB (SE) – SEK 390 million
Initial public offering of Intea Fastigheter AB (SE) on Nasdaq Stockholm – SEK 2,468 million Real Estate Initial public offering of Intea Fastigheter AB (SE) on Nasdaq Stockholm – SEK 2,468 million
Directed new share issue in Ferroamp AB (SE) — SEK 30 million Cleantech, Renewables & Infrastructure Directed new share issue in Ferroamp AB (SE) — SEK 30 million
Private placement in Thor Medical ASA (NO) — NOK 157.5 million Healthcare Private placement in Thor Medical ASA (NO) — NOK 157.5 million
Directed new share issue in PowerCell Sweden AB (SE) — SEK 190 million Cleantech, Renewables & Infrastructure Directed new share issue in PowerCell Sweden AB (SE) — SEK 190 million
Initial public offering of KB Components AB (SE) on Nasdaq Stockholm – SEK 638 million Industrials Initial public offering of KB Components AB (SE) on Nasdaq Stockholm – SEK 638 million
Placing of shares in OssDsign AB (SE) – SEK 40 million Healthcare Placing of shares in OssDsign AB (SE) – SEK 40 million
Sale of Miss Mary (SE) to enterstore (CZ) via Hartenberg Holding (CZ) by Scope Growth III L.P. (SE) Consumer & Retail Sale of Miss Mary (SE) to enterstore (CZ) via Hartenberg Holding (CZ) by Scope Growth III L.P. (SE)
Listing of Carasent AB (SE) on Nasdaq Stockholm Healthcare Listing of Carasent AB (SE) on Nasdaq Stockholm
Initial public offering of Apotea AB (SE) on Nasdaq Stockholm – SEK 1,880 million Consumer & Retail Initial public offering of Apotea AB (SE) on Nasdaq Stockholm – SEK 1,880 million